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ABSTRACT
Background: In GFR measurements with radiotracers, there is evidence that a two-compartment model is unable to describe 
the full plasma curve, including early time points, but analyses generally focus on two-compartment models.
aims: To analyze both the mammillary and catenary three-compartment model and to determine empirical relations between 
model constants and the overall GFR and ECV (extra-cellular volume).
material and methods: Mathematical analysis of the three-compartment model. Full-curve patient data from 32 adults 
and 7 children were used to relate model parameters to GFR and ECV.
results: Model volumes were found to be roughly proportional to ECV. In both models, the central (plasma) volume was 
V1 = 0.24 × ECV and elimination rate from V1 was k10 = 4.2 × GFR/ECV. In the mammillary model, the two parallel volumes were 
V2
 = 0.28 × ECV, V3 = 0.48 × ECV, and intercompartmental clearances were Cl12 [mL/min] = 0.0058 × ECV [mL], Cl13 = 0.042 
× ECV. In the catenary model, the serial volumes were V2 = 0.60 × ECV, V3 = 0.16 × ECV, with clearances Cl12 = 0.048 × ECV, 
Cl23 = 0.0036 × ECV. 
conclusion: Insight into the three-compartment model was achieved, and empirical relations to ECV and GFR/ECV were 
determined. 
key words: gFr-determination, pharmacokinetics, compartment model, tc-99m-dtPa
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Introduction 
Although inulin-clearance is still regarded as the gold standard in 
the glomerular filtration rate (GFR) assessment, radionuclide meth-
ods with application of chromium-51-ethylene-diamine-tetraacetate 
(Cr-51-EDTA) and technetium-99m-diethylele-triamine-pentaacetate 
(Tc-99m-DTPA) have the dominant position [1]. It is widely accepted 
that both radiotracers are characterized by a very similar behavior 
after injection to human plasma [2–5]. However, none of these 
papers developed a pharmacokinetic model of these tracers, i.e., 
it is still impossible to forecast the behavior of these tracers (con-
centrations, time-concentration curve parameters) in the plasma 
after injection. Fleming [6] analyzed a two-compartment model. 
However, description of the full plasma curve (including the fast early 
behavior) requires at least three exponential functions [7], which for 
a compartment model corresponds to at least three compartments. 
The aim of this study is to explore three-compartment mod-
els with central elimination and determine how the detailed pa-
rameters of the model relate to the GFR and extracellular volume 
(ECV). More specifically, based on the model and patient data, the 
study will attempt to predict the patient-specific micro-parameters of 
the compartment model, given the GFR and ECV of the patient, 
and thus to predict the behavior of the tracers in the plasma after 
the injection. 
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Theory of the compartment model 
and GFR determination
The models considered in this study are shown in Figure 1. 
They consist of the central compartment (1; i.e., the plasma) and 
two tissue-fluid compartments (2 and 3). Ci and Vi are the concen-
tration and the volume, respectively, of the compartment showed 
by the lower index. The sum of the volumes of all three compart-
ments makes together the extracellular volume (ECV). 
It is assumed that the radiotracer intercompartmental transport 
is passive with a rate that is proportional to the concentration. Ac-
cording to the widely accepted convention, the respective transport 
rate constants (k) have lower indices denoting the direction of the 
transport, e.g., k12 is the elimination rate constant from compart-
ment 1 to 2, k21 from 2 to 1. The k10 is the elimination rate constant 
from the compartment 1 to the environment, i.e., extraction of the 
tracer by the kidneys resulting in excretion from the blood to the 
bladder. 
Since the intercompartmental transport is passive, the following 
exemplary relationship is fulfilled: 
Cl12 = k12 × V1 = k21 × V2 {1}
where Cl12 is the intercompartmental clearance (the same in 
both directions). Additionally:
GFR = k10 × V1 {2}
In this work, volumes are expressed in milliliters [mL], time in 
minutes [min], clearances in mL/min, and elimination rate con-
stants in min-1. 
The terms kij, Vi and Clij are called the system micro-constants. 
The plasma concentration in any time point t following the bolus i.v.-
injection can be expressed with a three-exponential formula:
C1(t) =
i = 1
3
Âci × exp (–bi × t)  {3}
where the convention here will be that i=1 denotes the slowest, 
i=2 the middle, and i=3 the fastest component, i.e. b1 < b2 < b3. 
The above parameters bi and ci are called the system macro- 
or hybrid constants (or the curve parameters). The algorithm 
transforming the micro-constants into the hybrid-constants is given 
in the Appendix 1. 
The GFR (more precisely: the radiotracer clearance) can be 
calculated as: 
GFR =
Q
AUC
 {4}
where Q is the injected amount (activity) of the tracer, and AUC 
is the area under the plasma time-concentration curve (decay-cor-
rected). AUC in turn can be obtained as:
AUC =
i = 1
n
Â ci / bi  {5}
where n=3 in the case of three-exponential curve. 
Likewise, the total extracellular volume (ECV) can be calculated 
as [8]:
ECVfc = Q i = 1
n
Â
ci
bi
2
AUC2
 {6}
A set of time-concentration points can be transformed into 
the time-concentration curve by use of an algorithm referred to 
as “curve-stripping” or “curve peeling-off” [7, 9]. Because, in 
clinical circumstances, this procedure (engaging multiple plasma 
sampling) is cumbersome, methods for estimation of the GFR from 
the final slope of the curve have been developed, e.g. [7, 10, 11]. 
This allowed reducing the number of necessary plasma samples to 
just a few (even two) a few hours following the radiotracer injection. 
As mentioned in the introduction, a two-compartment model 
(2-C) cannot fully describe the plasma concentration curve 
[7]. The physiological reality may be even more complex than 
a three-compartment model, but the concentrations in the early 
phase change very fast and their precise determination is difficult, 
so an extraction of a four- or more-exponential curve from the 
time-concentration data is problematic. This limits the number of 
parameters that can robustly be modeled. A mathematical analy-
sis of a four-compartment (4-C) model would also be far more 
complicated [12–14]. 
Physiologically, GFR is primarily a result of the effectiveness of 
the kidneys. Except for k10, the kij parameters express the ability of 
tracer to move between body compartments not directly related 
to the kidneys. Our model will assume these kij parameters to be 
person-independent. Except for cases of edema, the compart-
ment volumes Vi will also be only little affected by renal function. 
Our model will assume Vi’s to scale with ECV, but otherwise be 
person-independent. Together, these two assumptions result in the 
expectation of Clij also scaling with ECV (cf. equation {1}). 
Both a mammillary and a catenary model will be investigated. 
The universal 3-compartment model (see Fig. 1) would involve more 
k parameters and is not considered in this study. 
Materials and methods
Patient inclusion criteria
The patient data were got from the database of Prof. Brøch-
ner-Mortensen used in previous works [7, 10, 11]. Inclusion criterion 
for the present study were measured plasma volume (and hence 
initial concentration), as well as concentration values measured 
Figure 1. The pharmacokinetic models with central elimination considered 
in this study (see the text for the explanations). In the mammillary model, 
Cl23 = k23 = k32 = 0; in the catenary model, Cl13 = k13 = k31 = 0
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in all of the time points 15, 30, 60, 90, 120, 150, 180, 210, 240, 
270 and 300 minutes. For the timing, up to 10% deviation from 
the time point was allowed (e.g. 30 ± 3 minutes was acceptable). 
This resulted in inclusion of 32 adults and 7 children. The patient 
group consisted of subjects with normal as well as with impaired 
renal function. For 4 adults and all 7 children, early time-points at 
5 and 10 minutes were also accessible.  
Reconstruction of the time-concentration curve
In the following, the original time-concentration points are 
referred to as “genuine points”. The time-concentration curve 
was reconstructed according to the procedure described origi-
nally by Brøchner-Mortensen [7]. Shortly, the parameters of the 
slowest component (slope, b1, and intercept, c1) were obtained 
by linear regression of the logarithmized 5 last time-concentration 
points (180 to 300 minutes). The reconstruction of the middle and 
the fastest component followed by the “curve-stripping” method; 
the numbers of the time-concentration points processed in each 
of these steps ranged from two to five. Thus, the complete 
three-exponential time-concentration curve was reconstructed 
(b1, b2, b3, c1, c2, c3). 
Establishing of input ECV, GFR and micro-constants 
for each patient
For the processing, only full-curve data were used. Full-curve 
results GFRfc and ECVfc were calculated with equations {4} to {6}. 
Then, the micro-constants of the mammillary model were 
determined for each patient separately using the algorithm given 
in the Appendix 2. 
Averaging and regression of the individual data
For each subject, the obtained micro-constants were divided 
by the ECV, and these data were averaged and regressed to 
obtain formulas for calculation of compartment volumes and in-
tercompartmental clearances as functions of ECV. We tested for 
normality and re-calculated from log-normal distribution for Cl12 
and Cl13. However, the procedure did not result in overall better 
fit (results not shown). Accordingly, calculations in the following 
are based on simple mean values and standard deviations (SD). 
These procedures were performed for all 39 patients together, 
as well as separately for adults and children. Then, possible 
dependences of V1/ECV, V2/ECV, V3/ECV, Cl12/ECV, Cl13/ECV on 
ECV and the subjects’ ages and gender were examined in order 
to verify, whether there is a relationship between these values, 
and to find the optimal set of input data needed for establishing 
of the model. 
Thus, a general three-compartment mammillary pharmacoki-
netic model was created. As shown below, the ECV and GFR were 
proven to be necessary and sufficient input values for transform-
ing of this general model into the theoretical patient-specific one. 
The general mammillary model served to create pattern 
time-concentration curves. They, in turn, were then transformed into 
the micro-constants of the three-compartment catenary model ac-
cording to the algorithm presented in the Appendix 3. We checked 
numerically that, for each general mammillary model, a general 
catenary model exists, which is equivalent in respect to the central 
compartment (i.e., the same ECV, V1, GFR and time-concentration 
curve in the V1). 
Evaluation of the averaged mammillary model
Evaluation from full-curve data 
The averaged mammillary model was evaluated using ECVfc 
and GFRfc as input. For a given patient, the model estimated curve 
parameters (b1, b2, b3, c1, c2, c3), and thereby also the plasma 
curves described by these parameters. 
Model curve parameters and plasma curve points were com-
pared with the “genuine” results from the full data. Comparison 
was done by calculation of the relative differences, calculated using 
the following formula:
RD = (G – M)/M {7}
where:
 RD: relative difference,
 G: genuine parameter,
 M: modeled parameter. 
It can be noted that RD express the deviation of the genuine 
data from the modeled data (M in the denominator), rather than the 
other way around. This is to avoid division by a noisy data point. 
The genuine data contain random noise, while the modeled data 
may contain bias but are averaged regarding noise. A positive 
RD corresponds to the genuine data point being higher than the 
model prediction.
Evaluation from slope-intercept data
Having full-curve data available is not the normal situation. So 
we extended the evaluation to use only the late (3–5 hours p.i.) data, 
i.e. the data used when GFR is calculated with the slope-intercept 
method.
In this case, GFR and ECV were calculated with the formulas of 
Jødal&Brøchner-Mortensen [8, 10, 11]:
GFRJBM =
GFRb
1 + ƒ × GFRb
, {8}
ECVJBM =
Vda
1 + 2 × ƒ × GFRb
, {9}
where
ƒ = 0.0032 × BSA–1,3 {10}
BSA is the body surface area [m2], while Vda and GFRb are the 
apparent volume of distribution and the GFR-value, respectively, 
obtained from the final slope of the time-concentration curve:
GFRb =
Q
c1 / b1
 {11}
Vda =
Q
c1
 {12}
Given GFRJBM and ECVJBM (instead of GFRfc and ECVfc) as input, 
evaluation proceeded as described above.
Results
General 3-C mammillary pharmacokinetic model
The averaging and regression of the all patients’ data delivered 
the ratios (average ± standard deviation, SD) presented in Table 1. 
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The largest correlation within the data was found between 
V1/ECV and ECV, but it was only r = –0.35; the absolute correlation 
coefficients between the rest of the examined parameters were 
lower than 0.2. Hence, these relationships were not taken into 
consideration in the data processing. 
Thus, the following formulas were established for the respective 
micro-constants in the general mammillary model, i.e. the plasma 
volume V1 in exchange with both V2 and V3 (but no exchange be-
tween V2 and V3):
V1 = 0.24 × ECV,
V2 = 0.28 × ECV,
V3 = 0.48 × ECV,
Cl12 = 0.0058 × ECV (hence: k12= 0.0242, k21= 0.0207),
Cl13 = 0.042 × ECV (hence: k13= 0.175, k31= 0.0876).
V1 = 0.24 × ECV,
Regarding k10 (cf. equation {2}):
k10 = GFR / V1 = 4.2 × GFR / ECV
General 3-C catenary pharmacokinetic model
In the catenary model, plasma volume V1 is in exchange with 
the middle volume V2 which is further in exchange with V3 (but there 
is no exchange between V1 and V3). Relations were:
V1 = 0.24 × ECV (as in the mammillary model),
V2 = 0.60 × ECV,
V3 = 0.16 × ECV,
Cl12 = 0.048 × ECV (hence: k12= 0.199, k21= 0.0794),
Cl23 = 0.0036 × ECV (hence: k23= 0.00599, k32= 0.0228).
As in the mammillary model:
k10 = GFR / V1 = 4.2 × GFR / ECV
Comparison of the reconstructed curve 
parameters and genuine concentrations to 
the values predicted by the mammillary model 
For both adults and children, the relative differences (RD in eq. 
{7}) of the macroparameters (Tab. 2) and concentrations (Fig. 2–5) 
were calculated twice. First using full-curve data for ECV and GFR 
as model input (fc-data), second using ECV and GFR calculated 
with the respective JBM-formula as model input (JBM-data). 
Discussion 
The resulting general models give theoretical compartment 
volumes and intercompartmental clearances which are simple 
fractions of the entire extracellular volume. It corresponds to assum-
ing that the intercompartmental exchange rates are independent 
from the ECV. A slight negative correlation between V1/ECV and 
ECV was found, but this correlation was considered weak. Indeed, 
a further pursuing of the weak relationship made all the resulting 
formulas for the respective compartment volumes and intercompart-
mental clearances (or elimination rate constants) more complicated, 
but the ultimate precision of the model remained virtually the same 
(data not presented). 
To our knowledge, this is the first study elucidating three-com-
partment pharmacokinetic models of these radiotracers, so that 
any prediction of the behavior of the tracer after its injection to 
a patient with known GFR and ECV is possible. Fleming presented 
a model with a single extra-vascular compartment [6], but such 
a compartment will correspond to a two-exponential plasma con-
centration. A two-exponential function can describe most of the 
plasma concentration curve, but cannot include the quick fall in 
the earliest part of the curve. 
Our model predicted the curve parameters and the concentra-
tions with similar accuracy when the full-curve GFR and ECV as well 
as the JBM-data served as the input. It leads to the conclusion 
that the model can be useful with the data just approached by the 
formulas from the late time-concentration points. It seems to ad-
ditionally support that the JBM formulas offer very reliable results in 
comparison to the full-curve data which in turn can be got only with 
a logistically cumbersome procedure of multiple blood withdraw-
als during a long time period in each patient. The application of the 
JBM formulas allows reducing the number of blood samplings to 
a few, sometimes even two, performed solely 3–5 hours following 
the injection. 
The predictions on the curve parameters and the concentra-
tions were generally less accurate in pediatric patients; espe-
cially the SD-values were higher: it seemed to hint at a higher 
table 1. Ratios of the computed model parameters to the ECV 
(mammillary model)
Ratio Mean ± SD
V1/ECV 0.240 ± 0.027
V2/ECV 0.283 ± 0.101
V3/ECV 0.477 ± 0.091
Cl12/ECV 0.00578 ± 0.00339
Cl13/ECV 0.0422 ± 0.0160
table 2: Relative differences (cf. eq. {7}) for macroparameters calculated 
either from genuine, individual patient data, or from the mammillary model 
predictions, using GFR and ECV as input. Differences are presented as 
mean (SD), separately for adults (n = 32) and children (n = 7)
Parameter Adults, 
fc-data *
Children,  
fc-data *
Adults, 
JBM-data† 
Children, 
JBM-data†
b1 –1.4 (3.9) % 0.71 (7.5) % 1.1 (1.9) % 2.8 (4.0) %
c1 –2.9 (8.9) % 1.5 (19) % 2.4 (4.6) % 6.4 (9.8) %
b2 –6.4 (34) % 20 (51) % –6.2 (34) % 21 (50) %
c2 3.0 (49) % 34 (54) % 12 (55) % 52 (70) %
b3 –5.4 (34) % 34 (21) % –5.2 (34) % 35 (21) %
c3 2.6 (16) % –3.9 (10) % 10 (22) % 4.2 (18) %
*Full-curve data were used to calculate GFR and ECV for model input
† Only late data points and the JBM corrections were used to calculate GFR and ECV for model 
input (slope-intercept method, cf. eqs. {8} and {9})
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interpersonal variability in the pediatric group rather than at a dif-
ferent set of averaged micro-parameters that should be used for 
pharmacokinetic studies. 
At the late time points, almost all genuine concentrations deviate 
from the modeled ones by no more than a few percent. It can be 
noticed from Figures 2–5, though, that deviations are somewhat 
systematic for the first hour or two, and largest for the earliest time 
points. A similar tendency can be observed for the curve param-
eters (Tab. 2). These factors hint at a higher interpersonal variability 
of the early phase as compared to the later phases. The following 
reasons seem to be potentially responsible for this phenomenon: 
First, the developed three-compartment mammillary model 
is only an approximation of the real biologic situation which in 
turn hypothetically could be described by a very complex multi-
compartment model. Still, the three-compartment model can be 
expressed as a unique analytical solution, as demonstrated here 
and elsewhere [12, 15, 16]. A four-compartment model, although 
potentially more punctual, is characterized by a much higher com-
plexity [13, 14]. For higher models, such analytic solutions have not 
been found, although numerical models exist. Moreover, whereas it 
is possible to create pharmacokinetic models with different num-
bers of compartments and parallel with the same late phase of the 
time-concentration curve, the early phases must show significant 
differences in such a comparison. 
Second, several factors contribute to the precision of the 
concentration measurement. Beyond the accuracy of the tim-
ing, sampling (volume) and counting, the place of the blood 
withdrawal seems to have a significance: The mathematical 
models assume a uniform distribution of the concentration within 
the entire blood, whereas it seems obvious that the concentration 
in the upper proximity vein (the most popular location of blood 
sampling) can differ from the concentration in, for example, renal 
vein or renal artery. These differences are the most pronounced 
in the early phase, where a rapid decrease of the serum con-
centration is observed. 
Moreover, all the calculations are performed with the next as-
sumption of instantaneous mixing of the injected radiotracer with 
the entire blood; this is the next condition that is actually not fulfilled. 
Hence, the practically measured early phase concentrations are 
more likely to differ from the model than the later phase. 
Summing up, a development of a theoretically more precise 
higher compartment model would constitute a mathematical chal-
lenge, and, practically, it would potentially give only little added 
value to the pharmacokinetics of the radiotracers applied in the 
Figure 2. Relative differences (RD ± SD) between genuine and model 
concentrations in the respective time points for adults, using full-curve 
values ECVfc and GFRfc as model input. For the time points 5 and 10 
minutes, n = 4, for the rest of the parameters, n = 32
Figure 3. Relative differences (RD ± SD) between genuine and model 
concentrations in the respective time points for children, using full-curve 
values ECVfc and GFRfc as model input; n = 7
Figure 4. Relative differences (RD ± SD) between genuine and model 
concentrations in the respective time points for adults, using final-slope 
values ECVJBM and GFRJBM as model input. For the time points 5 and 10 
minutes, n = 4, for the rest of the parameters, n = 32
Figure 5. Relative differences (RD ± SD) between genuine and model 
concentrations in the respective time points for children, using final-slope 
values ECVJBM and GFRJBM as model input; n = 7
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assessment of the glomerular filtration rate, with practically no 
possibility of its verification. 
Conclusions 
A model has been set up, which can be analytically studied. 
The model was to a reasonable extent able to reproduce the patient 
curves. The model is patient-specific in the sense that given GFR 
and ECV, it can be used to estimate the microconstants, and further 
the time-concentration curve parameters and the concentrations, 
for this patient.
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Appendix 1. Calculation of the hybrid- 
-constants from the micro-constants 
of the 3-C mammillary model
The formulas for the central compartment cited from [16], 
a similar algorithm is given in [17]. 
The concentration in the central compartment (plasma):
C1t = c1 × exp (–t × b1) + c2 × exp (–t × b2) + 
+ c3 × exp (–t × b3), {A1.1}
where index 1: the slowest component, 3: the fastest com-
ponent;
If the differential equations describing the concentrations in 
the compartments are transformed into the matrix, the charac-
teristic polynomial can be obtained [12, 15, 18]. The polynomial 
is simplified by the fact that k23 = k32 = 0 in the mammillary model. 
Combining the polynomial with the Vieta formulas delivers the fol-
lowing basic relationships:
1.: b1 × b2 × b3 = k10 × k21 × k31
2.: b1 × b2 + b1 × b3 + b2 × b3 = k10 × k31 + k21 × k31 + k21 × k13 + 
 + k10 × k21 + k31 × k12
3.: b1 + b2 + b3 = k10 + k12 + k13 + k21 + k31
Given the parameters from the compartment model in Figure 1 
(k10, k12, etc.), the parameters describing the shape of the plasma 
concentration curve (b1, c1, etc.) can be computed as summarized 
in the following. This summary is based on the derivation given in 
the above cited references. 
The following auxiliary quantities are defined:
a0 = k10 × k21 × k31
a1 = k10 × k31 + k21 × k31 + k21 × k13 + k10 × k21 + k31 × k12
a2 = k10 + k12 + k13 + k21 + k31
p = a1 – a2 / 3
3
p = 2 × a2 / 27 – a1 × a2 / 3 + a0
3
r1 = –(p3/27)
r2 = 2 × r1
1/3
ø = arccos / 3
q
2 × r1
–
The solution for the plasma curve parameters is then: 
b1 = –(cos(ø) × r2 – a2/3) {A1.2}
b2 = –  cos(ø +             ) × r2 – a2/3
4 × p
3
 {A1.3}
b3 = –  cos(ø +             ) × r2 – a2/3
2 × p
3
 {A1.4}
×c1 =
Q
V1
k21– b1
b1– b3
×
k31– b1
b1– b2
 {A1.5}
×c2 =
Q
V1
k21– b2
b2– b3
×
k31– b2
b2– b1
 {A1.6}
×c3 =
Q
V1
k21– b3
b3– b1
×
k31– b3
b3– b2
 {A1.7}
The concentrations in the other two compartments will follow 
sums of the same exponentials but with other factors. 
For the peripheral fast compartment, the curve is:
Cfast(t) = F × exp (–b1 × t) + K × exp
(– b2 × t) – (F+K) × exp(–b3 × t) {A1.8}
where
×F =
Q
V1
k21– b1
b1– b3
×
k31
b1– b2
,  {A1.9}
×K =
Q
V1
k21– b2
b2– b3
×
k31
b2– b1
. {A1.10}
For the peripheral slow compartment, the curve is:
Cslow(t) = H × exp (–b1 × t) + J × exp
(–b3 × t)–(H+J) × exp(–b2 × t) {A1.11}
where
×H =
Q
V1
k21
b1– b3
×
k31–b1
b1– b2
,  {A1.12}
×J =
Q
V1
k21
b3– b1
×
k31–b3
b3– b2
. {A1.13}
Appendix 2. Calculation of the micro-
constants from the hybrid-constants in the 
three-compartment mammillary model with 
central elimination
This appendix can be considered a reversal of the algorithm 
presented in Appendix 1. A similar algorithm is derived in [17]. 
Knowns: b1, c1, b2, c2, b3, c3; additionally, GFRfc and ECVfc can 
be calculated with the formulas given in the section II [Theory of the 
compartment model and GFR determination section].
At t = 0, activity Q is injected into V1 (the plasma compartment), 
with no activity in V2 and V3. Total initial concentration is 
C1(0) = c1 + c2 + c3, 
leading to:
V1 =
Q
c3 + c2 + c3
. {A2.1}
The excretion rate constant is
k10 =
GFRfc
V1
.  {A2.2}
For the mammillary model, k23 = k32 = 0. In the following, equa-
tions for k12, k21, k13 and k31 will be derived.
Calculation of the intercompartmental 
elimination rate constants:
The three-exponential plasma time-concentration formula 
{A1.1} is used. The derivative of C1(t) is the change of plasma 
(compartment 1) concentration for any time. Initial rate of change is:
dC1/dt |t=0 = – c1 × b1 – c2 × b2 – c3 × b3. 
At t = 0 there is no tracer in compartments 2 and 3, so from 
the compartment model:
dC1/dt |t=0 = – (k10 + k12 + k13) × C1(0)
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Equating these two expressions for the initial derivative and 
inserting C1(0), one receives:
c1 × b1 + c2 × b2 + c3 × b3
c1 + c2 + c3
k10 + k12 + k13 = .
The variable P is defined as the sum of rate constants leading 
from the first compartment to the other compartments (but not 
excretion):
c1 × b1 + c2 × b2 + c3 × b3
c1 + c2 + c3
P = k12 + k13 = – k10 .
where the rewriting allows calculation of P from the param-
eters known at this point.
The variable R is defined as the sum of rate constants leading 
into the first compartment:
R = k21 + k31 = b1 + b2 + b3 – (k10 + k12 + k13)
where the latter equal sign follows from the third basic relation-
ship (Appendix 1). Inserting the above equation for k10 + k12 + k13 
and rewriting, one receives: 
R = k21 + k31 =
= 
c2 × b1 + c3 × b1 + c1 × b2 + c3 × b2 + c1 × b3 + c2 × b2
c1 + c2 + c3
allowing calculation of R.
The variable S is defined as the product of k21 and k31. From the 
first basic relationship (Appendix 1) one receives:
S = k21 × k31 = b1 × b2 × b3/k10.
allowing calculation of S.
Combining the variables R and S, a quadratic equation in k21 
can be set up and solved:
k21 = 0.5 × R – R
2 – 4 × S . {A2.3}
From the definition of R:
k31 = R – k21. {A2.4}
The variable L is defined as a sum of products of the exponential 
constants (all of which are known, allowing calculation of L). From 
the second basic relationship:
L = k10 × k31 + k21 × k31 + k21 × k13 + k10 × k21 + k31 × k12 =
= b1 × b2 + b1 × b3 + b2 × b3,
The variable N is defined as:
N = k13 × k21 + k12 × k31 = L – R × 10 – S.
Given the definition of P (and k21 and k31 already being calcu-
lated), this allows calculation of k12:
k12 = (k31 – k21)
N – P × k21
. {A2.5}
Finally, the last non-zero rate constant is
k13 = P – k12.  {A2.6}
Volumes of the peripheral compartments and intercompart-
mental clearances
From the relations mentioned in section II we get:
V2 = V1 × k12/k21 {A2.7}
V3 = V1 × k13/k31 {A2.8}
and
Cl12 = k12 × V1 {A2.9}
Cl13 = k13 × V1 {A2.10}
The mammillary model has Cl23 = 0.
Appendix 3. Calculation of the micro-
constants from the hybrid-constants 
in the three-compartment catenary model 
with central elimination
Similarly as in the Appendix 1, the following basic relation-
ships can be derived for the catenary model (where k13 = k31 = 0):
(1.): b1 × b2 × b3 = k10 × k21 × k31
(2.): b1 × b2 + b2 × b3 + b1 × b3 = k10 × (k21 + k23 × k32) + k12 × 
 × (k23 + k32) + k21 × k32
(3.): b1 + b2 + b3 = k10 + k12 + k23 + k32 + k21
Given are: b1, b2, b3, c1, c2, c3. Again, GFR and ECV can be 
calculated with equations {4} to {6}.
From these data, one may obtain:
C1(0) = c1 + c2 + c3
V1 = Q/(c1+c2+c3)  {A3.1}
k10 = GFR/V1 {A3.2}
As in Appendix 2:
dC1/dt |t=0 = – c1 × b1 – c2 × b2 – c3 × b3. 
In the catenary model, there is no direct contact between the 
first and the third compartment, so the initial derivative from the 
model is different from Appendix 2:
dC1/dt |t=0 = –(k10 + k12) × C1(0)
Hence:
k12= (c1 × b1 + c2 × b2 + c3 × b3)/(c1 + c2 + c3) – k10 {A3.3}
The variable R is defined as
R= k21 + k23 + k32 = b1 + b2 + b3 – (k10 + k12)
where the third relation has been used.
The variable S is defined as:
S = k21 × k32 = b1 × b2 × b3/k10
where the first relation has been used.
Using the second relation, the variable L is defined as:
L = k23 + k32 
= [b1 × b2 + b2 × b3 + b1 × b3 – k21 × k32 – k10 × (k21 + k23 + k32)] / k12
= [b1 × b2 + b2 × b3 + b1 × b3 – S – k10 × R] / k12
R, S and L can all be computed from the input data and the 
already-computed k12.
k21 = R – L {A3.4}
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From the first relation:
k32 = b1 × b2 × b3 / (k10 × k21) {A3.5}
From the third relation: 
k23 = b1 + b2 + b3 – (k10 + k12 + k32 + k21) {A3.6}
Then:
V2 = V1 × k12/k21 {A3.7}
V3 = ECV – V1 – V2 {A3.8}
Cl12 = k12 × V1 {A3.9}
Cl23 = k23 × V2 {A3.10}
